Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- ForsLean Improves Body Composition According to Study Published in the Journal of Obesity Research
Results in August 2005 Journal of Obesity Research indicate that that ForsLean(R) promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Phytochemicals May Protect Cartilage, Prevent Pain in Joints
Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme.
- Geni Herbs Announces PomElla® Clinical Study Plan
Current studies involving phase-2 human clinicals explore the in vivo effects of PomElla on heart disease risk factors in people with cardiovascular problems, as well as its in vivo antioxidant capacity and bioavailability. Research beginning in 2006 includes further studies exploring the mechanisms involved in optimizing cardio health with PomElla.
- Geni Herbs Announces PomElla® Clinical Study Plan
Current studies involving phase-2 human clinicals explore the in vivo effects of PomElla on heart disease risk factors in people with cardiovascular problems, as well as its in vivo antioxidant capacity and bioavailability. Research beginning in 2006 includes further studies exploring the mechanisms involved in optimizing cardio health with PomElla.
- Geni Herbs Announces PomElla® Clinical Study Plan
Current studies involving phase-2 human clinicals explore the in vivo effects of PomElla on heart disease risk factors in people with cardiovascular problems, as well as its in vivo antioxidant capacity and bioavailability. Research beginning in 2006 includes further studies exploring the mechanisms involved in optimizing cardio health with PomElla.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities
MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- AHPA Asks FDA, NCCAM to Portray Supplements Honestly
Association challenges the FDA and the National Center for Complementary and Alternative Medicine to tell the truth and to correct past misstatements about dietary supplements and echinacea products, respectively.
- Study Confirms BioLogic Health Solutions' MenoLogic (TM) Cream Reduces Menopause Symptoms
Company announces results of a 5-month Australian randomized, double-blind, placebo controlled study of 23 menopausal women, published in the International Journal of Naturopathic Medicine indicating that MenoLogic (TM) ingredient is effective in reducing symptoms associated with menopause.
- Study Confirms BioLogic Health Solutions' MenoLogic (TM) Cream Reduces Menopause Symptoms
Company announces results of a 5-month Australian randomized, double-blind, placebo controlled study of 23 menopausal women, published in the International Journal of Naturopathic Medicine indicating that MenoLogic (TM) ingredient is effective in reducing symptoms associated with menopause.
- Nexrutine® Shown Effective In New Open-Label Study
288 patients at the Living Longer Clinic in Cincinnati, OH participated in the study, of which 88% of the patients noted that the product reduced pain and/or inflammation and increased mobility and flexibility.
- Nexrutine® Shown Effective In New Open-Label Study
288 patients at the Living Longer Clinic in Cincinnati, OH participated in the study, of which 88% of the patients noted that the product reduced pain and/or inflammation and increased mobility and flexibility.
- Sen. Durbin Introduces, Withdraws AER Amendment
Sen. Richard Durbin (D-Ill.) introduced and promptly withdrew an amendment to the Defense Authorization Act that would have prohibited the sale of certain dietary supplements on military bases if manufacturers did not have a system to report adverse events to the government.
- Sen. Durbin Introduces, Withdraws AER Amendment
Sen. Richard Durbin (D-Ill.) introduced and promptly withdrew an amendment to the Defense Authorization Act that would have prohibited the sale of certain dietary supplements on military bases if manufacturers did not have a system to report adverse events to the government.
- NCCAM Revises Report of Echinacea Study, Notes Criticism of Low Dose
The National Center for Complementary and Alternative Medicine has revised its website to correct erroneous statements it had made previously about a study on low-dose preparations of Echinacea angustifolia root published in the New England Journal of Medicine on July 28, 2005.
- NCCAM Revises Report of Echinacea Study, Notes Criticism of Low Dose
The National Center for Complementary and Alternative Medicine has revised its website to correct erroneous statements it had made previously about a study on low-dose preparations of Echinacea angustifolia root published in the New England Journal of Medicine on July 28, 2005.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Study Finds Cranberries Have Novel Bacteria-Blocking Benefits
Rutgers University research, published in the current issue of Phytochemistry, indicates that cranberry juice cocktail exhibited anti-adhesion activity following a single serving, based on activity of its natural condensed tannins, called proanthocyanidins, or PACs; cranberry contains unusual A-type PAC linkage.
- Burcon Announces Technology Advancements - Expands Protein Applications
Company announces that it has successfully developed modifications to its patented protein extraction process that improve the physical and functional properties of Puratein(R) and Supertein(TM) which is expected to enable their use in a broader array of food and beverage applications.
- Burcon Announces Technology Advancements - Expands Protein Applications
Company announces that it has successfully developed modifications to its patented protein extraction process that improve the physical and functional properties of Puratein(R) and Supertein(TM) which is expected to enable their use in a broader array of food and beverage applications.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
Latest study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Study Indicates That Relora® Significantly Reduces Stress, Anxiety and Sleep Latency
Findings presented at the WorldNutra Conference indicate in randomized, placebo-controlled, parallel-group, clinical trial of 40 healthy, overweight, physically active, 25-50 year old women , that Spielberger Trait Total and Anxiety Index scores improved significantly and Relora group had twice as much average reduction in sleep latency as the placebo group.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Dietary Fat Intake Linked to Dry Eye Syndrome in Women
Study, published in the October 2005 issue of the American Journal of Clinical Nutrition indicates that women with the highest levels of omega 3 in their diets reduced their risk of dry eye syndrome by 20 percent compared to women with the lowest levels of this fat in their diet and that a dietary ratio of omega 6 to omega 3 greater than 15:1 was associated with a 2.5-fold increased risk of dry eye syndrome in women.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- New Study Published in Leading Toxicology Journal Concludes Chromax(R) Chromium Picolinate is Safe
Study, to be published in an upcoming issue of the Journal of Mutation Research, Genetic Toxicology and Environmental Mutagenesis, conducted by BioReliance Corporation and monitored by ENVIRON Health Sciences, concludes that Chromax(R) chromium picolinate does not produce chromosomal aberrations in Chinese Hamster Ovary (CHO) cells.
- New Study Published in Leading Toxicology Journal Concludes Chromax(R) Chromium Picolinate is Safe
Study, to be published in an upcoming issue of the Journal of Mutation Research, Genetic Toxicology and Environmental Mutagenesis, conducted by BioReliance Corporation and monitored by ENVIRON Health Sciences, concludes that Chromax(R) chromium picolinate does not produce chromosomal aberrations in Chinese Hamster Ovary (CHO) cells.
- New Study Published in Leading Toxicology Journal Concludes Chromax(R) Chromium Picolinate is Safe
Study, to be published in an upcoming issue of the Journal of Mutation Research, Genetic Toxicology and Environmental Mutagenesis, conducted by BioReliance Corporation and monitored by ENVIRON Health Sciences, concludes that Chromax(R) chromium picolinate does not produce chromosomal aberrations in Chinese Hamster Ovary (CHO) cells.
- New Study Published in Leading Toxicology Journal Concludes Chromax(R) Chromium Picolinate is Safe
Study, to be published in an upcoming issue of the Journal of Mutation Research, Genetic Toxicology and Environmental Mutagenesis, conducted by BioReliance Corporation and monitored by ENVIRON Health Sciences, concludes that Chromax(R) chromium picolinate does not produce chromosomal aberrations in Chinese Hamster Ovary (CHO) cells.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Carotech Announces New Study Linking Tocomin® to Protection Against Stroke-Induced Neurodegeneration
NIH-funded study conducted at the Ohio State University Medical Center, published in the October issue of the American Heart Association’s journal STROKE, indicates that rats supplemented with Tocomin® showed more protection against stroke-induced injury compared to unsupplemented controls.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Medical Journal Publishes Trial Showing Study Results of COLD-fX(R)
The Canadian Medical Association Journal will publish results of double-blind, placebo-controlled study on COLD-fX(R) for prevention and relief of upper respiratory infections; results indicate that the number of upper respiratory infections in each subject was significantly reduced by 25%, recurrent infections were reduced by 56%, and treatment also had a significant effect in reducing the total symptom score and the duration of infections.
- Annual Bibliography of Significant Advances in Dietary Supplement Research 2004
This sixth issue of the Bibliography includes abstracts of the 25 most noteworthy dietary supplement research papers published in 2004, as judged by an international team of reviewers; This is the first issue of the Bibliography to highlight research on phenolics and flavonoids.
- Annual Bibliography of Significant Advances in Dietary Supplement Research 2004
This sixth issue of the Bibliography includes abstracts of the 25 most noteworthy dietary supplement research papers published in 2004, as judged by an international team of reviewers; This is the first issue of the Bibliography to highlight research on phenolics and flavonoids.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
A new study from Leatherhead Food International has shown that Raftilose®, the prebiotic ingredient from ORAFTI, can significantly lower the glycemic index of food products, when used in replacement for sugar.
Malvern, PA (October 18, 2005) - Low glycemic index diets are favored by celebrities and nutritionists alike because they are linked to weight control and health benefits. In contrast, research has associated long-term high GI (glycemic index) diets with heart disease and diabetes.
Until now, sweet treats have often been off the menu for weight-conscious consumers as they tend to have a higher GI. This is because sugars, such as glucose, are absorbed into the blood quickly stimulating a large glucose and insulin response.
Low GI ice-cream
In a new study, funded by food ingredients companies, scientists at Leatherhead Food International created a new range of lower GI ice-creams using sugar replacers and/or oligofructose (Raftilose® from ORAFTI). These were tested in volunteers against a traditional sugary ice-cream to discover if the glycemic response improved.
Twelve healthy volunteers (5 men and 7 women, average age 31 years) ate ice-creams containing 15% Raftilose® (oligofructose) or different types of sugar replacers. They also ate the traditional ice-cream containing 15% sucrose (table sugar), or a glucose load. Blood levels of glucose were measured over a 2 hour period, and used to work out the glycemic response.
Lower glycemic response
The Raftilose® ice-cream gave a glycemic response which was 70% lower than the glycemic response produced after eating the traditional ice-cream. This lower glucose release is thought, by scientists, to be better for the metabolism. Commenting on the research, Dr. Anne Franck, Executive Vice-President Science and Technology from ORAFTI said: “Adding oligofructose instead of sucrose significantly reduced the glycemic response to eating the ice-cream”.
Adaptable prebiotics
The prebiotic ingredients Raftiline® and Raftilose® can improve the nutritional profiles of a wide range of food and beverage products. Backed by a considerable body of scientific research, these prebiotics are best known for improving gut health and well-being. The GI-lowering capability of Raftilose® adds to a list of impressive technical properties, including the ability to replace dietary fat without sacrificing mouthfeel and to replace sugar without impacting on taste.
-xxx-
Notes:
The glycemic index (GI) is commonly used to rank the (available) carbohydrate content of a food on a scale of 1 to 100 assuming that a glucose drink will give you a value of 100.
Glycemic response was calculated by testing volunteers’ blood glucose levels over a 2 hour period after they had eaten different types of ice-cream. These results were compared with blood glucose levels after consumption of a glucose drink.
The oligofructose ice-cream gave a glycemic response of 13, while the traditional ice-cream gave a glycemic response of 44.
About ORAFTI Group:
ORAFTI Group is a subsidiary of the Belgian agro-food group Raffinerie Tirlemontoise/ Tiense Suikerraffinaderij and is part of the ORAFTI/PALATINIT Ingredients Group of Südzucker (Germany)
ORAFTI Group produces Raftiline® (inulin) and Raftilose® (oligofructose), as well as Raftisweet® (fructose syrups), from chicory roots. ORAFTI Group's head office is in Tienen, Belgium and the company operates in more than 70 countries world wide, with production units in Oreye (Belgium), Wijchen (Netherlands) and Wijgmaal (Belgium). The ORAFTI Group also includes REMY INDUSTRIES, world leading producer of rice starches (Remyline®/ Remygel®), rice flours (Remyflo®) and rice proteins (Remypro®).
-xxx-
For more business information contact:
ORAFTI
www.orafti.com |